Table 1. Genes differentially expressed in ITGA11-KD cells compared with control cells characterized in the Human Fibrosis PCR Array (RT2 Profiler PCR Array PAHS-0120Z, SABiosciences) and analyzed using the provided RT Profiler PCR Array Data Analysis v. 3.5 software.
Gene symbol | Refseq | Description | Fold regulation |
---|---|---|---|
Profibrotic and inflammatory cytokines | |||
ACTA2 | NM_001613 | Actin, alpha 2, smooth muscle, aorta | −1.8557 |
CCL2 (MCP1) | NM_002982 | Chemokine (C-C motif) ligand 2 | −4.2634 |
IL-1B | NM_000576 | Interleukin 1, beta | −4.0615 |
Extracellular matrix, ECM remodeling and cell adhesion | |||
COL1A2 | NM_000089 | Collagen, type I, alpha 2 | −2.4318 |
MMP1 | NM_002421 | Matrix metallopeptidase 1 (interstitial collagenase) | −60.6317 |
MMP3 | NM_002422 | Matrix metallopeptidase 3 (stromelysin 1, progelatinase) | −5.0002 |
MMP9 | NM_004994 | Matrix metallopeptidase 9 (gelatinase B, 92 kDa gelatinase, 92 kDa type IV collagenase) | −1.948 |
TIMP1 | NM_003254 | TIMP metallopeptidase inhibitor 1 | −2.0167 |
TIMP3 | NM_000362 | TIMP metallopeptidase inhibitor 3 | −2.6427 |
PLAT | NM_000930 | Plasminogen activator, tissue | −1.9079 |
PLAU | NM_002658 | Plasminogen activator, urokinase | −3.6351 |
SERPINE1 | NM_000602 | Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | −2.2377 |
ITGA2 | NM_002203 | Integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | −4.8299 |
Signal transduction (TGFβ superfamily and transcription factors) | |||
CEBPB | NM_005194 | CCAAT/enhancer binding protein (C/EBP), beta | −1.9616 |
STAT1 | NM_007315 | Signal transducer and activator of transcription 1 | −1.8557 |
TGFBR1 | NM_004612 | Transforming growth factor, beta receptor 1 | −1.9752 |
TGFBR2 | NM_003242 | Transforming growth factor, beta receptor 2 | −1.948 |
TGIF1 | NM_003244 | TGFB-induced factor homeobox 1 | −2.0591 |
THBS1 | NM_003246 | Thrombospondin 1 | 3.1123 |
THBS2 | NM_003247 | Thrombospondin 2 | −1.8947 |
Bold characters indicate genes upregulated or downregulated by ⩾1.8-fold.